MedPath

Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project

Recruiting
Conditions
Undifferentiated Round Cell Sarcoma
Interventions
Other: data collection and analysis on Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissue
Registration Number
NCT05357768
Lead Sponsor
Istituto Ortopedico Rizzoli
Brief Summary

Experimental study with biological material : case series review of clinical and histological data

Detailed Description

This is a multicenter retrospective and prospective study that will analyze all cases with a diagnosis of Undifferentiated round cell sarcomas from 01 January 1983 and all new cases referring to each participant site.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
  • Clinical and outcome information available.
  • Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.
Exclusion Criteria
  • Diagnosis different from undifferentiated round cell sarcomas
  • Patient with no clinical or outcome information available

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
retrospective cohortdata collection and analysis on Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissuePatients with undifferentiated round cell sarcomas treated from 01 January 1983 to April 2019 will be included. For retrospective analysis, it is expected to include about 200 patients.
prospective cohortdata collection and analysis on Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissueprospective patients with undifferentiated round cell sarcomas will be included in the study. For prospective study, it is expect to include 60 patients.
Primary Outcome Measures
NameTimeMethod
event free survivalbaseline

Correlate clinical and pathological variables with event-free survival and overall-survival in undifferentiated round cell sarcomas.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IRCCs Istituto Ortopedico Rizzoli

🇮🇹

Bologna, BO, Italy

© Copyright 2025. All Rights Reserved by MedPath